Showing results (101-110 of 250) with videos related to
Sort By:
Pageof 25
Annals of Internal Medicine|April 1, 1979
Autopsy diagnosis of Legionnaires' disease in immunosuppressed patients. A paleodiagnosis using Giemsa stain (Wohlbach modification)J K Frenkel, L H Baker, A M ChonkoJournal of Chromatography|January 11, 1985
Reversed-phase high-performance liquid chromatographic determination of tricyclic nucleoside and tricyclic nucleoside 5'-phosphate in biological specimensR B Schilcher, J D Young, L H BakerAmerican Journal of Clinical Oncology|December 1, 1994
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomasS C Blair, M M Zalupski, L H BakerCancer|December 1, 1976
Phase II study of mitomycin-C, vincristine, and bleomycin in advanced squamous cell carcinoma of the uterine cervixL H Baker, M I Opipari, R M IzbickiJournal of Surgical Oncology|October 1, 1985
Progress in screening for early breast cancerL H Baker, T D Chin, K V WagnerInvestigational New Drugs|January 1, 1984
Phase I and pharmacologic evaluation of nafazatrom in patients with cancerC D Haas, L H Baker, L J EvansCancer|February 15, 1993
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinomaR Pazdur, J A Ajani, Y Z Patt, et al.Investigational New Drugs|May 1, 1993
Evaluation of amonafide in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, K J Kopecky, V Sondak, et al.Cancer Treatment Reports|October 1, 1986
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology GroupJ D Cox, M K Samson, A M Herskovic, et al.Clinical Pharmacology and Therapeutics|September 13, 2016
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung CancerG K Raju, K Gurumurthi, R Domike, et al.Pageof 25